Community 365 Roundtable Meeting on Lung Cancer

The second Community 365 Roundtable Meeting on Lung Cancer, held on an invitation-only basis, brought together leading policy-makers, politicians, oncology experts and patient advocates to launch the Essential Requirements for Quality Cancer Care: Lung Cancer and to discuss this important topic. 

07 December 2020 15:00 - 17:00 CET

Virtual Event

The full report from the meeting will be published in January 2021.

Lung Cancer Roundtable 2020

  • View the recording of the Roundtable meeting here.
  • Download the Action Report 'Leave No One Behind - Delivering Innovation in Lung Cancer Care' here.
  • Download the Roundtable meeting presentation slides here.
  • Review the Roundtable meeting thread on Twitter here.

 

The full programme is as follows: 

15:00–15:05    Welcome and Introduction 

Matti Aapro, President of the European Cancer Organisation is co-chair of this two-hour meeting, together with colleagues from Community 365 for different sections of the meeting. 

15:05–15:20   Essential Requirements for Quality Cancer Care: Lung Cancer

Yolande Lievens, Co-Chair of the new Essential Requirements on Quality Cancer Care: Lung Cancer presents a summary of the paper. 

15:20–15:30    Open Discussion on the New Essential Requirements   

Including contributions from Irena Joveva MEP, Anne-Marie Baird, Lung Cancer Europe (LuCE) and Helmut Prosch, European Society of Radiology (ESR).

15:30–16:00    Early Detection and Screening  

The focus for this session is the need for early diagnosis and screening in Lung Cancer, highlighting that now is the time to determine implementation roadmaps across Europe.   

Matti Aapro co-chairs this section of the meeting with Françoise Bartoli, VP, Head of Europe and Canada, Oncology Business, AstraZeneca and includes a presentation by Giorgio Scagliotti, Professor of Oncology, University of Turin and Chief of the Medical Oncology Division at the S. Luigi Hospital.  

This presentation will be followed by a discussion including Jan van Meerbeeck, European Respiratory Society (ERS), Frances Fitzgerald MEP, Helmut Prosch, European Society of Radiology (ESR) and Anne-Marie Baird, Lung Cancer Europe (LuCE). 

16:00–16:30    Molecular Diagnostics in Lung Cancer - Considerations and Relevance for Treatment Selection

This session is co-chaired by Matti Aapro and Geoff Oxnard, Vice President, Global Medical Lead, Liquid Franchise at Foundation Medicine and former Associate Professor of Medicine at Harvard Medical School. It focuses on Equitable access in Europe to multi-disciplinary molecular tumour boards and to high-quality Comprehensive Genomic Profiling based on NGS technology for lung cancer patients embedded in an appropriate infrastructure. It will include a presentation from Matthew Krebs, Clinical Senior Lecturer in Experimental Cancer Medicine, University of Manchester and Consultant in Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK, followed by an open discussion including the Secretary General of the European Respiratory Society, Joanna Chorostowska.

16:30–17:00    The Dutch Lung Cancer Audit: Nationwide Quality of Care Evaluation Using Quality Indicators 

The final session is co-chaired by Matti Aapro and Ouzna Morsli, EMEAC Oncology Medical Lead at MSD and will include a presentation on a case study on the importance of quality indicators from the Netherlands by Hans J.M. Smit, MD, PhD, Pulmonologist Rijnstate Hospital, Chairman of the Dutch Lung Cancer Audit, Arnhem, The Netherlands and Rawa Ismail, PharmD and PhD Candidate DICA. 

This presentation will be followed by a discussion including Jan van Meerbeeck, European Respiratory Society (ERS),  Helmut Prosch, European Society of Radiology (ESR) and Anne-Marie Baird, Lung Cancer Europe (LuCE).

 

For those of you that did not attend the first Community 365 Roundtable Meeting on Inequalities, you can view a video of the meeting and see the slides presented here.

Speakers

  • Matti Aapro President, European Cancer Organisation and EU Cancer Mission Assembly Member
  • Yolande Lievens Co-Chair of the Essential Requirements for Quality cancer Care for Lung Cancer
  • Irena Joveva MEP Member of the European Parliament
  • Frances Fitzgerald MEP Member, Committee on Economic and Monetary Affairs
  • Anne-Marie Baird Member, Patient Advisory Committee and President, Lung Cancer Europe
  • Françoise Bartoli VP, Head of Europe and Canada, Oncology Business, AstraZeneca

Speakers

  • Matti Aapro President, European Cancer Organisation and EU Cancer Mission Assembly Member
  • Yolande Lievens Co-Chair of the Essential Requirements for Quality cancer Care for Lung Cancer
  • Irena Joveva MEP Member of the European Parliament
  • Frances Fitzgerald MEP Member, Committee on Economic and Monetary Affairs
  • Anne-Marie Baird Member, Patient Advisory Committee and President, Lung Cancer Europe
  • Françoise Bartoli VP, Head of Europe and Canada, Oncology Business, AstraZeneca
  • Matti Aapro President, European Cancer Organisation and EU Cancer Mission Assembly Member Read Bio
  • Yolande Lievens Co-Chair of the Essential Requirements for Quality cancer Care for Lung Cancer
  • Irena Joveva MEP Member of the European Parliament
  • Frances Fitzgerald MEP Member, Committee on Economic and Monetary Affairs Read Bio
  • Anne-Marie Baird Member, Patient Advisory Committee and President, Lung Cancer Europe Read Bio
  • Françoise Bartoli VP, Head of Europe and Canada, Oncology Business, AstraZeneca
  • Rawa Ismail PharmD and PhD Candidate DICA
  • Matthew Krebs Clinical Senior Lecturer in Experimental Cancer Medicine, University of Manchester and Consultant in Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
  • Jan Van Meerbeeck Board Member, European Cancer Organisation and Thoracic Oncology Assembly Head, European Respiratory Society Read Bio
  • Ouzna Morsli EMEAC Oncology Medical Lead, MSD
  • Geoff Oxnard Vice President, Global Medical Lead, Liquid Franchise at Foundation Medicine Read Bio
  • Helmut Prosch European Society of Radiology (ESR)
  • Giorgio Vittorio Scagliotti Professor of Oncology, University of Torino Read Bio
  • Hans J.M. Smit Pulmonologist Rijnstate Hospital, Chairman of the Dutch Lung Cancer Audit, Arnhem, The Netherlands
  • Joanna Chorostowska Secretary General, European Respiratory Society

Speakers

  • Matti Aapro President, European Cancer Organisation and EU Cancer Mission Assembly Member
  • Yolande Lievens Co-Chair of the Essential Requirements for Quality cancer Care for Lung Cancer
  • Irena Joveva MEP Member of the European Parliament
  • Frances Fitzgerald MEP Member, Committee on Economic and Monetary Affairs
  • Anne-Marie Baird Member, Patient Advisory Committee and President, Lung Cancer Europe
  • Françoise Bartoli VP, Head of Europe and Canada, Oncology Business, AstraZeneca

Speakers

  • Matti Aapro President, European Cancer Organisation and EU Cancer Mission Assembly Member
  • Yolande Lievens Co-Chair of the Essential Requirements for Quality cancer Care for Lung Cancer
  • Irena Joveva MEP Member of the European Parliament
  • Frances Fitzgerald MEP Member, Committee on Economic and Monetary Affairs
  • Anne-Marie Baird Member, Patient Advisory Committee and President, Lung Cancer Europe
  • Françoise Bartoli VP, Head of Europe and Canada, Oncology Business, AstraZeneca